FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Vaccines and Related Biological Products Advisory Committee

horizontal rule

July 27, 2000 Meeting

Date and Time

The meeting will be held on July 27, 2000, from 8:00 am to 4:00 pm.

Location

Holiday Inn, Versailles Ballrooms I, II, and III, 8120 Wisconsin Avenue, Bethesda, MD, 301-652-2000

Contact Person

William Freas, Sheila D. Langford, Nancy Cherry, or Denise Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), codes 12392 and 12388. Please call the Information Line for up-to-date information on this meeting.

Oral Presentations

Between approximately 1:00 and 2:00 pm oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before July 17, 2000.

Agenda

On July 27, 2000, from 9:00 am to 4:00 pm , the meeting is open to the public. In joint session, the committees will discuss bovine spongiform encephalopathy issues related to the manufacture of vaccines, specifically the use of European fetal calf serum in cell banks and viral seeds, and the use of European beef skeletal muscle and other tissues in manufacturing vaccines.

Closed Committee Deliberations

From 8:00 until 9:00 am the meeting will be closed to permit discussion and review of trade secret and/or confidential information (5 U.S.C. 552b(c)(4)).

Preliminary Summary

 

 
horizontal rule